Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

Clinical trial NCT00061750 · COMPLETED

Trial details

NCT number: NCT00061750
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Beta-Thalassemia

Start date: 2003-05-01
Primary completion: 2004-11-01
Enrollment: 595

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.